ProShare Advisors LLC Has $844,000 Position in Sanofi (NASDAQ:SNY)

ProShare Advisors LLC cut its holdings in Sanofi (NASDAQ:SNY) by 9.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,390 shares of the company’s stock after selling 1,807 shares during the quarter. ProShare Advisors LLC’s holdings in Sanofi were worth $844,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. POM Investment Strategies LLC bought a new position in Sanofi in the 2nd quarter valued at $25,000. Register Financial Advisors LLC acquired a new stake in Sanofi in the first quarter worth about $29,000. Larson Financial Group LLC raised its holdings in Sanofi by 480.8% during the 1st quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after purchasing an additional 500 shares during the last quarter. Palisade Asset Management LLC acquired a new position in Sanofi during the 1st quarter valued at about $31,000. Finally, Arrow Financial Corp acquired a new stake in shares of Sanofi during the 2nd quarter worth approximately $35,000. 10.04% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on SNY. Argus raised their price target on Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. StockNews.com raised shares of Sanofi from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Finally, Citigroup raised shares of Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Sanofi presently has a consensus rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Stock Performance

Shares of SNY stock opened at $57.65 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. Sanofi has a 52 week low of $42.63 and a 52 week high of $58.97. The company’s 50 day moving average price is $55.04 and its two-hundred day moving average price is $50.82. The company has a market capitalization of $146.01 billion, a P/E ratio of 28.97, a price-to-earnings-growth ratio of 1.62 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, July 25th. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.88 by $0.05. Sanofi had a net margin of 9.60% and a return on equity of 26.29%. The business had revenue of $10.75 billion for the quarter, compared to analysts’ expectations of $16.86 billion. During the same period in the previous year, the firm posted $0.95 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. On average, analysts expect that Sanofi will post 4.26 earnings per share for the current fiscal year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.